Form 4 for RMD ResMed|
Accepted 2025-11-18 00:00:00 ET · period of report 2025-11-14 · accession 0000943819-25-000122 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-18 | 2025-11-14 | RMD | FARRELL PETER C | Dir | M - OptEx | $101.64 | +11.4K | 77.6K | +17% | +$1.16M |
| D | 2025-11-18 | 2025-11-14 | RMD | FARRELL PETER C | Dir | F - Tax | $244.46 | -7,314 | 70.2K | -9% | -$1.79M |
| D | 2025-11-18 | 2025-11-14 | RMD | FARRELL PETER C | Dir | M - OptEx | $0.00 | -11.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2025-11-14 | M | A | 11,442 | $101.64 | 77,552 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2025-11-14 | F | D | 7,314 | $244.46 | 70,238 | D | — | — | |
| 3 | Derivative | ResMed Common Stock Options | 2025-11-14 | M | D | 11,442 | $0.00 | 0 | D | $101.64 · 2019-11-11 to 2025-11-14 | 11,442 ResMed Common Stock |